Identification and management of Alzheimer’s Disease (AD)Diadem Presents Data at 2023 AAIC® Showing Its AlzoSure® Blood Test Can Identify Patients at High Risk of Significant Cognitive Decline Due to Alzheimer’s DiseaseIdentification and management of Alzheimer’s Disease (AD)

Diadem Presents Data at 2023 AAIC® Showing Its AlzoSure® Blood Test Can Identify Patients at High Risk of Significant Cognitive Decline Due to Alzheimer’s Disease —Data from 479-Patient Study Confirms Strong Prognostic Utility of AlzoSure® Predict for Identifying...